HKSE - Delayed Quote HKD

Clover Biopharmaceuticals, Ltd. (2197.HK)

Compare
0.218
-0.002
(-0.91%)
At close: January 28 at 12:08:04 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-727,878.000
-727,878.000
-1,690,809.000
-917,749.000
476,927.000
Investing Cash Flow
-6,161.000
-6,161.000
-37,506.000
112,124.000
-394,120.000
Financing Cash Flow
-142,408.000
-142,408.000
483,143.000
3,057,173.000
316,847.000
End Cash Position
735,864.000
735,864.000
1,607,409.000
2,767,371.000
516,184.000
Capital Expenditure
-9,176.000
-9,176.000
-105,560.000
-80,316.000
-113,792.000
Issuance of Capital Stock
84.000
84.000
453,155.000
3,765,561.000
330,911.000
Issuance of Debt
460,792.000
460,792.000
293,833.000
--
--
Repayment of Debt
-444,591.000
-444,591.000
--
--
--
Repurchase of Capital Stock
--
--
--
-530,179.000
--
Free Cash Flow
-737,054.000
-737,054.000
-1,796,369.000
-998,065.000
363,135.000
12/31/2020 - 11/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers